<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02858466</url>
  </required_header>
  <id_info>
    <org_study_id>1308144</org_study_id>
    <secondary_id>2013-A01440-45</secondary_id>
    <nct_id>NCT02858466</nct_id>
  </id_info>
  <brief_title>Structural and Functional Brain Reorganization in Neuropathic Pain: Basal State of Local Cerebral Blood Flow and Functional Connectivity</brief_title>
  <acronym>CONNECT</acronym>
  <official_title>Structural and Functional Brain Reorganization in Neuropathic Pain: Basal State of Local Cerebral Blood Flow and Functional Connectivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neuropathic pain is a medical condition involving allodynia (painful perceptions in response
      to stimuli that normally are not) and spontaneous pain (occurring at rest, without
      stimulation).

      This pain is secondary to nervous system injury affecting the sensory system. The lesion is
      either at the nerve endings of the spinal cord or brain.

      It induces a loss of sensitivity and likely reorganization of brain activity that are causing
      pain and which are the subject of this study.

      Previous studies in functional neuroimaging has focused on brain areas activated during
      allodynic stimuli compared to non-painful stimuli. The abnormalities have been reported, but
      it was not possible to conclude formally. The authors failed to assess the part of the effect
      of the loss of sensory afferents (deafferentation) and the basal brain function.

      Indeed, the operation without any sensory stimulation is not known yet is the initial level
      of activity which is the benchmark for studying brain function during stimulation. The
      objective of this study is to understand what are the cortical systems of allodynic
      dysfunctional in patients compared with controls at baseline.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 25, 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cerebral blood flow</measure>
    <time_frame>at baseline</time_frame>
    <description>quantified with MRI scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of grey matter</measure>
    <time_frame>at baseline</time_frame>
    <description>difference between groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>structure of the networks</measure>
    <time_frame>at baseline</time_frame>
    <description>Determine if structure of the networks is different between patients and controls.
Measured with MRI scan.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>connection of the networks</measure>
    <time_frame>at baseline</time_frame>
    <description>Determine if connection of the networks is different between patients and controls.
Measured with MRI scan.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cortical loss</measure>
    <time_frame>at baseline</time_frame>
    <description>Assess the cortical loss of the patient group compared to controls. Measured with MRI scan.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Neuropathic Pain</condition>
  <arm_group>
    <arm_group_label>peripheric nervous lesion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRI scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medullar or encephalic lesion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRI scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>MRI scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>MRI scan</intervention_name>
    <arm_group_label>peripheric nervous lesion</arm_group_label>
    <arm_group_label>medullar or encephalic lesion</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for patients :

          -  major

          -  with nervous pain : chronic or peripheric

          -  treatment not stable opioid since one week

          -  signed consent

        Inclusion Criteria for witnesses :

          -  major

          -  without chronic pain

          -  signed consent

        Exclusion Criteria for 2 groups :

          -  severe psychiatric history

          -  presence of an active nervous lesion

          -  subject with morphine treatment

          -  contraindication to MRI scan
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roland PEYRON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de SAINT-ETIENNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roland PEYRON, MD</last_name>
    <phone>(0)477127805</phone>
    <phone_ext>+33</phone_ext>
    <email>roland.peyron@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carine LABRUYERE, CRA</last_name>
    <phone>(0)477120469</phone>
    <phone_ext>+33</phone_ext>
    <email>carine.labruyere@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de SAINT-ETIENNE</name>
      <address>
        <city>Saint-etienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland PEYRON, MD</last_name>
      <phone>(0)477127805</phone>
      <phone_ext>+33</phone_ext>
      <email>roland.peyron@chu-st-etienne.fr</email>
    </contact>
    <contact_backup>
      <last_name>Carine LABRUYERE, CRA</last_name>
      <phone>(0)477120469</phone>
      <phone_ext>+33</phone_ext>
      <email>carine.labruyere@chu-st-etienne.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2016</study_first_posted>
  <last_update_submitted>February 14, 2018</last_update_submitted>
  <last_update_submitted_qc>February 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

